Dracocephalum palmatum Stephan extract induces caspase‑ and mitochondria‑dependent apoptosis via Myc inhibition in diffuse large B cell lymphoma

Kim,Jisu; Kim,Jeong Nam; Park,Inmyoung; Sivtseva,Sardana; Okhlopkova,Zhanna; Zulfugarov,Ismayil S.; Kim,Sang‑Woo

doi:10.3892/or.2020.7797

Dracocephalum palmatum Stephan extract induces caspase‑ and mitochondria‑dependent apoptosis via Myc inhibition in diffuse large B cell lymphoma

Authors:
- Jisu Kim
- Jeong Nam Kim
- Inmyoung Park
- Sardana Sivtseva
- Zhanna Okhlopkova
- Ismayil S. Zulfugarov
- Sang‑Woo Kim
View Affiliations

Affiliations: Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea, Department of Microbiology, Pusan National University, Busan 46241, Republic of Korea, Department of Asian Food and Culinary Arts, Youngsan University, Busan 48015, Republic of Korea, Department of Biology, North‑Eastern Federal University, Yakutsk 677027, Russia, Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea
Published online on: October 8, 2020 https://doi.org/10.3892/or.2020.7797
Pages: 2746-2756

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dracocephalum palmatum Stephan (DPS), a medicinal plant used by Russian nomads, has been known to exhibit antioxidant properties. However, to the best of our knowledge, its anticancer effect has not been elucidated. The present study aimed to evaluate the tumor‑suppressive effect of DPS extract (DPSE) in diffuse large B cell lymphoma (DLBCL) and the underlying mechanism. MTS assays and Annexin V staining were performed to assess the anti‑proliferative and apoptotic effects of DPSE, respectively. To reveal the underlying mechanisms, the levels of pro‑ and anti‑apoptotic Bcl‑2 members were analyzed by western blotting. Rescue experiments were performed to investigate the potential involvement of Myc in DPSE‑induced tumor‑inhibitory effects. Additionally, high‑performance liquid chromatography analysis was performed to analyze the components with anticancer effects. Exposure of multiple DLBCL cell lines to DPSE significantly decreased cell viability and increased apoptosis, whereas it had no effect on the survival of normal cells in vitro and in vivo. This indicates that its cytotoxic effect may be specific to cancer cells. Mechanistically, cell death induced by DPSE was dependent on the activation of caspase‑3/7 and the disruption of mitochondrial membrane potential. Treatment with the extract ameliorated the expression of anti‑apoptotic Bcl‑2 members Bcl‑xL and Mcl‑1, and upregulated that of pro‑apoptotic Bcl‑2 members Bax and Bak. These modulations led to the disruption of mitochondrial membrane potential, which culminated in the activation of executioner caspases‑3 and ‑7. Notably, overexpression of Myc inhibited DPSE‑induced cell killing, indicating the involvement of Myc in this process. Given that dysregulation of Myc is strongly associated with the pathobiology of DLBCL, the present study highlights the potential therapeutic efficacy of DPSE in patients with DLBCL with aberrant Myc expression. Furthermore, fractionation of DPSE by thin layer chromatography and liquid chromatography/mass spectrometry‑based investigation of the fraction with bioactive compounds demonstrated that flavonoids may be responsible for most, if not all, of the anti‑lymphoma effect. Efforts to identify the bioactive flavonoids is currently underway.

View Figures

View References

1	Lenz G and Staudt LM: Aggressive lymphomas. N Engl J Med. 362:1417–1419. 2010. View Article : Google Scholar : PubMed/NCBI
2	Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
3	Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, Bertoni F, Ponzoni M, Scandurra M, Califano A, et al: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 459:717–721. 2009. View Article : Google Scholar : PubMed/NCBI
4	Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 346:235–242. 2002. View Article : Google Scholar : PubMed/NCBI
5	Coiffier B: Rituximab therapy in malignant lymphoma. Oncogene. 26:3603–3613. 2007. View Article : Google Scholar : PubMed/NCBI
6	Pasqualucci L and Dalla-Favera R: The genetic landscape of diffuse large B-cell lymphoma. Semin Hematol. 52:67–76. 2015. View Article : Google Scholar : PubMed/NCBI
7	Hengartner MO: The biochemistry of apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
8	Cleveland JL and Ihle JN: Contenders in FasL/TNF death signaling. Cell. 81:479–482. 1995. View Article : Google Scholar : PubMed/NCBI
9	Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
10	Green DR: The coming decade of cell death research: Five riddles. Cell. 177:1094–1107. 2019. View Article : Google Scholar : PubMed/NCBI
11	Green DR and Reed JC: Mitochondria and apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
12	Olennikov DN, Chirikova NK, Okhlopkova ZM and Zulfugarov IS: Chemical composition and antioxidant activity of Tánara Ótó (Dracocephalum palmatum Stephan), a medicinal plant used by the North-Yakutian nomads. Molecules. 18:14105–14121. 2013. View Article : Google Scholar : PubMed/NCBI
13	Jeong D, Kim J, Nam J, Sun H, Lee YH, Lee TJ, Aguiar RC and Kim SW: MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas. Leukemia. 29:1868–1874. 2015. View Article : Google Scholar : PubMed/NCBI
14	Kim E, Nam J, Chang W, Zulfugarov IS, Okhlopkova ZM, Olennikov D, Chirikova NK and Kim SW: Angelica gigas Nakai and decursin downregulate Myc expression to promote cell death in B-cell lymphoma. Sci Rep. 8:105902018. View Article : Google Scholar : PubMed/NCBI
15	Nam J, Kim DU, Kim E, Kwak B, Ko MJ, Oh AY, Park BJ, Kim YW, Kim A, Sun H, et al: Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival. Leukemia. 33:2912–2923. 2019. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Kao SH, Wang WL, Chen CY, Chang YL, Wu YY, Wang YT, Wang SP, Nesvizhskii AI, Chen YJ, Hong TM and Yang PC: Analysis of protein stability by the cycloheximide chase assay. Bio Protoc. 5:e13742015. View Article : Google Scholar : PubMed/NCBI
18	Chipuk JE and Green DR: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18:157–164. 2008. View Article : Google Scholar : PubMed/NCBI
19	Trabucco SE, Gerstein RM, Evens AM, Bradner JE, Shultz LD, Greiner DL and Zhang H: Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma. Clin Cancer Res. 21:113–122. 2015. View Article : Google Scholar : PubMed/NCBI
20	Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, et al: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 146:904–917. 2011. View Article : Google Scholar : PubMed/NCBI
21	Zheng GQ: Cytotoxic terpenoids and flavonoids from Artemisia annua. Planta Med. 60:54–57. 1994. View Article : Google Scholar : PubMed/NCBI
22	Ott G, Rosenwald A and Campo E: Understanding MYC-driven aggressive B-cell lymphomas: Pathogenesis and classification. Blood. 122:3884–3891. 2013. View Article : Google Scholar : PubMed/NCBI
23	Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H and Clarke AR: Myc deletion rescues Apc deficiency in the small intestine. Nature. 446:676–679. 2007. View Article : Google Scholar : PubMed/NCBI
24	Kwak B, Kim DU, Kim TO, Kim HS and Kim SW: MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer. Int J Oncol. 53:1800–1808. 2018.PubMed/NCBI
25	Sewastianik T, Prochorec-Sobieszek M, Chapuy B and Juszczyński P: MYC deregulation in lymphoid tumors: Molecular mechanisms, clinical consequences and therapeutic implications. Biochim Biophys Acta. 1846:457–467. 2014.PubMed/NCBI
26	Li W, Gupta SK, Han W, Kundson RA, Nelson S, Knutson D, Greipp PT, Elsawa SF, Sotomayor EM and Gupta M: Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. J Hematol Oncol. 12:732019. View Article : Google Scholar : PubMed/NCBI
27	Tan Z, Zhang X, Kang T, Zhang L and Chen S: Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells. Drug Des Devel Ther. 12:3913–3927. 2008. View Article : Google Scholar
28	Ho JS, Ma W, Mao DY and Benchimol S: p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol. 25:7423–7431. 2005. View Article : Google Scholar : PubMed/NCBI
29	Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 435:677–681. 2005. View Article : Google Scholar : PubMed/NCBI
30	van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, et al: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell. 10:389–399. 2006. View Article : Google Scholar : PubMed/NCBI
31	Zhao B and Hu M: Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncol Lett. 6:1749–1755. 2013. View Article : Google Scholar : PubMed/NCBI
32	Pettit GR, Zhang Q, Pinilla V, Herald DL, Doubek DL and Duke JA: Isolation and structure of gustastatin from the Brazilian nut tree Gustavia hexapetala. J Nat Prod. 67:983–985. 2004. View Article : Google Scholar : PubMed/NCBI
33	Malagón O, Ramirez J, Andrade JM, Morocho V, Armijos C and Gilardoni G: Phytochemistry and ethnopharmacology of the Ecuadorian flora. A review. Nat Prod Commun. 11:297–314. 2016.PubMed/NCBI
34	García-Fortanet J, Debergh JR and De Brabander JK: A photochemical entry to depsides: Synthesis of gustastatin. Org Lett. 7:685–688. 2005. View Article : Google Scholar : PubMed/NCBI
35	Kroemer G, Galluzzi L and Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev. 87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
36	Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR and Newmeyer DD: Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 111:331–342. 2002. View Article : Google Scholar : PubMed/NCBI
37	Labisso WL, Wirth M, Stojanovic N, Stauber RH, Schnieke A, Schmid RM, Krämer OH, Saur D and Schneider G: MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors. Cell Cycle. 11:1593–1602. 2012. View Article : Google Scholar : PubMed/NCBI
38	Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI